Remove Article Remove Medication Delivery Remove Pharmaceutical Companies
article thumbnail

Pharma’s post-pandemic launch performance problem: what’s the prognosis?

pharmaphorum

Lockdowns are no longer; but the more hybrid model of physician and patient engagement is here to stay; the challenge for launching companies is how to optimise engagement impact and patient opportunity within them. To find out more about the issues discussed in this article, visit www.iqvia.com and search for “Launch Excellence”.